Alen David Swinamer

Title: Alen David Swinamer: Innovator in Pharmaceutical Compounds

Introduction

Alen David Swinamer is a notable inventor based in Woodbury, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Swinamer holds a patent for "Pyrazole compounds as CCR1 antagonists." This patent discloses compounds that block the interaction of CCR1 and its ligands. These compounds are useful for treating various diseases and disorders mediated by CCR1 activity, including autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The patent also covers pharmaceutical compositions that include these compounds, methods for their use in treatment, and processes for preparing these compounds and their intermediates.

Career Highlights

Alen David Swinamer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on innovative solutions to complex medical challenges, contributing to advancements in therapeutic options for patients.

Collaborations

Swinamer collaborates with talented professionals in his field, including Brian Nicholas Cook and Christian Harcken. These partnerships enhance the research and development efforts within the pharmaceutical industry.

Conclusion

Alen David Swinamer's contributions to pharmaceutical innovations, particularly through his patent on CCR1 antagonists, highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments for autoimmune diseases and other disorders.